Betsabeh Madani

Betsabeh is a strategy executive with 14 years of operating and commercialization experience and has held senior management, strategy and advisory positions across a portfolio of companies in healthcare and biotech (3-26,000 employees, $5M-$26B Market Cap). She is a strong advocate for impactful innovation and economic development, supporting founders and empowering the growth of the deep science driven start-up community.
Betsabeh is currently an Entrepreneur in Residence at Innovation Boulevard and a senior advisor to two healthcare/life sciences investors across North-America. Previously at Cerner, she led corporate strategy for healthcare predictive analytics as
well as population health programs where she acted as GM for Diabetes and Health Failure programs. In addition, she spearheaded corporate venturing initiatives. As a Director at MITACS, she built and managed cross sectoral industry-academia engagements across Canada. More recently, at EquicareHealth, she served as the Vice President of Strategy and led both market positioning and vertical growth across chronic illnesses with a focus on the Oncology care space.
Outside of work, Betsabeh judges engineering and start-up competitions, mentors women in STEM, and volunteers her time advising early stage start-ups across cleantech, agriculture and healthcare solutions.
A scientist and an engineer by training, her academic research background covers Proteomics, Biophysics and Bio-Mechanical Engineering. During her time as a researcher she investigated the physical properties of Indoleamine 2-3 dioxygenase and Heme Proteins.
Betsabeh holds an MBA from Tuck School of Business at Dartmouth, a Master of Engineering in Biomechanical Engineering from UBC, and an Honors Bachelor’s in Physics and in Biochemistry from UVic.